The streamlined protocol for isolation and characterization of Fc-expressing proteins is routinely used to process chimeric murine galectin-1 fused to human Fc (Gal-1hFc) from dilute cell culture supernatants. The flowchart in Figure 2 illustrates the workflow and time for each step in the protocol. For a typical batch of 300 ml of supernatant, the total processing time is approximately 9 hr when the optional flow cytometry testing of elution fractions is performed. If all flow cytometry analysis is omitted, due to lack of a flow cytometer or individual lab preference, total processing time can be as brief as 4 hr. In general, processing time depends on operator experience, amount of supernatant processed, and which quantification and characterization methods are performed.
Flow cytometry was used to test for the presence of functional Gal-1hFc (i.e. Gal-1 able to detect its ligands on breast cancer cells) in the starting cell culture supernatant; fresh cell culture medium served as the negative control18,22 . Once Gal-1hFc in the cell culture supernatant was verified (Figure 3A), loading of the protein A membrane adsorber was accomplished by supernatant perfusion at 10 ml/min (resulting in superficial velocity or volumetric flux of 0.5 cm/min in a 2 ml membrane adsorber) using a syringe pump (Figure 1). The membrane adsorber efficiently captured and retained Gal-1hFc, leaving the flow through essentially depleted of Gal-1hFc (lack of breakthrough, Figure 3A). Gal-1hFc was eluted from the membrane adsorber in one milliliter increments at 1 ml/min (volumetric flux = 0.05 cm/min) using an amine-based acidic buffer (pH 2.8), and neutralized elution fractions were subsequently tested for the presence of functional Gal-1hFc using flow cytometry (Figure 3B). Gal-1hFc signal sequentially increased from elution 1 (approximately equal to negative control) to a maximum at elution 3, then decreased to a nearly constant level at elutions 9 and 10 (Figures 3B and 3C). The final elution 10 did not reach equivalence to the negative control signal due to some adsorber retention of Gal-1hFc (Figures 3B and 3C). However, this loss was deemed acceptable. As an alternative method to test for presence, but not function, of Gal-1hFc in various solutions, flow cytometry analysis of Gal-1hFc's ability to bind to protein A polystyrene beads (through recognition of the hFc region) can be used (Figure 3D).
Following elution fraction testing, Gal-1hFc-positive elutions 2 through 10 were concentrated and then dialyzed against DPBS to obtain purified Gal-1hFc in the desired buffer. Quantification and characterization of the purified Gal-1hFc was performed in a Western blotting procedure expedited by semidry transfer and vacuum-assisted immunoblotting. By comparing Gal-1hFc signal to hFc quantification standards, both the quantity and quality of purified material were determined (Figures 4A-C). Signal intensities of hFc standard bands (one band at ~25 kDa each in Figure 4A, lanes 1-5) were linearly related to the quantity of hFc present (Figure 4C). Gal-1hFc (one band at ~40 kDa in Figure 4A, lane 6) and degraded Gal-1hFc (one band at ~40 kDa and one band at ~25 kDa in Figure 4A, lane 7) signals were within the standards range (Figure 4A, lanes 1-5). The concentration of purified Gal-1hFc (Figure 4A, lane 6) on the basis of hFc was determined to be 450 µg/ml by image processing (Figure 4C). Adjusting for the molecular weight of Gal-1hFc, the concentration of the purified material was 720 g/ml. In contrast, too much purified Gal-1hFc was loaded in lanes 6 and 7 of the Western in Figure 4B, which generated signals that saturated or exceeded the hFc standards range, thereby preventing quantification. Alternative to Western blotting, Coomassie gel staining21 can serve as a rapid quality control check and/or quantification method (Figure 4D). Note that a band ~10 kDa, in addition to bands ~25 kDa and ~40 kDa, was present in the degraded Gal-1hFc sample (Figure 4D, lane 2). This band is degraded Gal-1hFc that was nonreactive with the detection antibody used in Western blots (Figures 4A and 4B).
After quantification and final characterization of the purified Gal-1hFc, sterile BSA was added to achieve a final BSA concentration of 0.5%. The purified material was then aliquoted and stored at -20 ºC. In addition to Gal-1hFc, we have used this streamlined protocol to isolate double mutant Gal-1hFc and Gal-7hFc. It can also be extended to practically any molecule that possesses an Fc fragment (antibodies, Fc fragments themselves, other Fc fusion proteins, etc. of species and isotypes that have affinity for protein A14-17).

Figure 1. Schematic of the experimental apparatus. Antibodies and recombinant fusion proteins expressing Fc fragments of IgG can be isolated from dilute solutions using a protein A membrane adsorber. The membrane adsorber is connected through a Luer lock fitting to a 30 ml syringe on a syringe pump, which perfuses the protein-containing solution through the membrane adsorber at a desired volumetric flow rate.

Figure 2. Process workflow for the isolation of Gal-1hFc from cell culture supernatant. This flowchart illustrates the protocol for the isolation and characterization of a chimeric murine galectin-1/human Fc-expressing fusion protein (Gal-1hFc) from cell culture supernatant. In general, processing time will vary depending on operator experience, amount of supernatant processed, and which quantification and characterization methods are used.

Figure 3. Flow cytometry analysis of Gal-1hFc-containing solutions. Flow cytometry is used to assess whether functional Gal-1hFc is present in fresh cell culture medium, cell culture supernatant, membrane adsorber flow through, and elution fractions. APC-conjugated F(ab')2 anti-human Fc was used as the secondary antibody. All data were acquired using a FACS Aria Special Order Research Product flow cytometer/sorter and analyzed using FlowJo software. Markers in each histogram represent 2% of negative control population (i.e. fresh cell culture medium for (A) and hFc isotype for (B)). (A) Flow cytometry histogram overlay of BT-20 breast cancer cells labeled with fresh cell culture medium (red), cell culture supernatant (blue), or membrane adsorber flow through (green). Cell culture supernatant contained a low level of functional Gal-1hFc that successfully bound to galectin-1 ligands on BT-20 cells, while the fresh cell culture medium and membrane adsorber flow through lacked Gal-1hFc, as expected. (B) Flow cytometry histograms of BT-20 cells labeled with elution fractions from the membrane adsorber. Gal-1hFc signal on the BT-20 cells sequentially increases to a maximum at elution 4 then decreases, although not to background level (i.e. signal equivalent to fresh cell culture medium). (C) The mean fluorescence intensities of the samples in (B) can also be plotted as a function of elution fraction number to generate an elution curve. The mean fluorescence intensity of cells labeled with hFc isotype control is shown as a reference line. (D) Alternatively, flow cytometry analysis of Gal-1hFc bound to protein A polystyrene beads can be used to test for protein presence, but not function, in various solutions. APC-conjugated F(ab')2 anti-human Fc was used as the secondary antibody. Left: Flow cytometry histogram overlay of fresh cell culture medium (red), cell culture supernatant (blue), and blank buffer sample (green). Middle: Histogram of hFc isotype control. Incubation with 10 mg/ml hFc is a positive control for protein A capture. Right panel: Histogram of protein A beads incubated with purified Gal-1hFc, on the basis of 10 mg hFc/ml. Click here to view larger image.

Figure 4. Quantification and characterization of Gal-1hFc using Western blotting and image analysis. (A) Lanes 1-5 are hFc standards of 0.1-0.5 μg in 0.1 μg increments, and lanes 6 and 7 are purified Gal-1hFc from two different production lots. Samples were resolved on a 4-15% TGX gel by SDS-PAGE under reducing conditions, then transferred to PVDF membrane using discontinuous transfer conditions. The membrane was blocked and incubated with anti-hIgG-AP using a vacuum-assisted immunoblotting technique. Signals were developed with ECL reagent and visualized on a Bio-Rad ChemiDoc XRS imager. Signals for hFc standards in lanes 1-5 varied linearly (plotted in (C)), and the signals for the two purified Gal-1hFc samples in lanes 6 and 7 were within the linear measurement range. Lane 7 shows two bands, Gal-1hFc and presumably hFc fragment, indicating degradation of the protein. (B) If too much purified Gal-1hFc is loaded, the signal may saturate or exceed the linear signal range, preventing quantification (lanes 6 and 7). Lanes, gel, and running conditions are the same as in (A). (C) Image Lab analysis software allows the input of known absolute quantities of hFc standards from an immunoblot, then determines the quantity of the unknown band(s) through its signal relative to the linear regression of standards (y = 1.36 x 10-7*x + 0.105; R2 = 0.95). Data shown are from the analysis of the immunoblot in (A). (D) Quality of purified Gal-1hFc can be assessed using Coomassie staining. Lane M is a molecular weight marker, lane 1 is purified Gal-1hFc (same sample as lane 6 in (A) and (B)), lane 2 is degraded Gal-1hFc (same sample as lane 7 in (A) and (B)), and lane 3 is 0.2 mg hFc standard. Gel and running conditions were the same as in (A) and (B). Click here to view larger image.